eprintid: 10135926
rev_number: 12
eprint_status: archive
userid: 608
dir: disk0/10/13/59/26
datestamp: 2021-10-07 13:06:55
lastmod: 2021-10-07 13:06:55
status_changed: 2021-10-07 13:06:55
type: article
metadata_visibility: show
creators_name: Muller, P
creators_name: Gurol-Urganci, I
creators_name: Thakar, R
creators_name: Ehrenstein, MR
creators_name: Van Der Meulen, J
creators_name: Jha, S
title: Impact of a mid-urethral synthetic mesh sling on long-term risk of systemic conditions in women with stress urinary incontinence: a national cohort study
ispublished: inpress
divisions: UCL
divisions: B02
divisions: C10
divisions: D17
divisions: G90
keywords: autoimmune disease, colposuspension, fascial sling, fibromyalgia, incontinence surgery, midurethral synthetic mesh sling insertion, myalgic encephalomyelitis, severe adverse events, stress urinary incontinence, systemic conditions, urogynaecology
note: © 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
abstract: OBJECTIVE: To compare the incidence of systemic conditions between women who had surgical treatment for stress incontinence with mesh and without mesh. DESIGN: National cohort study. SETTING: English National Health Service. POPULATION: Women with no previous record of systemic disease who had first-time urinary incontinence surgery between 1 January 2006 and 31 December 2013, followed up to the earliest of 10 years or 31 March 2019. METHODS: Competing-risks regression was used to estimate hazard ratios (HR), adjusted for patient characteristics, with HR > 1 indicating increased incidence following mesh surgery. MAIN OUTCOME MEASURES: First post-operative admission with a record of autoimmune disease, fibromyalgia or myalgic encephalomyelitis up to 10 years following the first incontinence procedure. Competing-risks regression was used to estimate hazard ratios (HR) of admission, adjusted for patient characteristics, with HR > 1 indicating increased incidence following mesh surgery. RESULTS: The cohort included 88 947 women who had mesh surgery and 3 389 women who had non-mesh surgery. Both treatment groups were similar with respect to age, socio-economic deprivation, comorbidity, and ethnicity. The 10-year cumulative incidence of autoimmune disease, fibromyalgia or myalgic encephalomyelitis was 8.1% (95% confidence interval 7.9% to 8.3%) in the mesh group and 9.0% (8.0% to 10.1%) in the non-mesh group (adjusted HR 0.89 [0.79 to 1.01]; p = 0.07). A sensitivity analysis including only autoimmune diseases as an outcome returned a similar result. CONCLUSIONS: These findings do not support claims that synthetic mesh slings cause systemic disease.
date: 2021-09-15
date_type: published
official_url: https://doi.org/10.1111/1471-0528.16917
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 1890621
doi: 10.1111/1471-0528.16917
lyricists_name: Ehrenstein, Michael
lyricists_id: MEHRE20
actors_name: Flynn, Bernadette
actors_id: BFFLY94
actors_role: owner
full_text_status: public
publication: BJOG: An International Journal of Obstetrics and Gynaecology
event_location: England
citation:        Muller, P;    Gurol-Urganci, I;    Thakar, R;    Ehrenstein, MR;    Van Der Meulen, J;    Jha, S;      (2021)    Impact of a mid-urethral synthetic mesh sling on long-term risk of systemic conditions in women with stress urinary incontinence: a national cohort study.                   BJOG: An International Journal of Obstetrics and Gynaecology        10.1111/1471-0528.16917 <https://doi.org/10.1111/1471-0528.16917>.    (In press).    Green open access   
 
document_url: https://discovery.ucl.ac.uk/id/eprint/10135926/1/1471-0528.16917.pdf